Align Technology Debt to Equity Ratio 2012-2026 | ALGN
Current and historical debt to equity ratio values for Align Technology (ALGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Align Technology debt/equity for the three months ending March 31, 2026 was 0.00.
| Align Technology Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $2.17B | $4.15B | 0.52 |
| 2025-12-31 | $2.19B | $4.05B | 0.54 |
| 2025-09-30 | $2.28B | $3.96B | 0.58 |
| 2025-06-30 | $2.31B | $3.91B | 0.59 |
| 2025-03-31 | $2.31B | $3.79B | 0.61 |
| 2024-12-31 | $2.36B | $3.85B | 0.61 |
| 2024-09-30 | $2.42B | $3.94B | 0.61 |
| 2024-06-30 | $2.40B | $3.76B | 0.64 |
| 2024-03-31 | $2.40B | $3.76B | 0.64 |
| 2023-12-31 | $2.45B | $3.63B | 0.68 |
| 2023-09-30 | $2.52B | $3.80B | 0.66 |
| 2023-06-30 | $2.51B | $3.64B | 0.69 |
| 2023-03-31 | $2.42B | $3.48B | 0.70 |
| 2022-12-31 | $2.35B | $3.60B | 0.65 |
| 2022-09-30 | $2.22B | $3.70B | 0.60 |
| 2022-06-30 | $2.21B | $3.60B | 0.61 |
| 2022-03-31 | $2.28B | $3.67B | 0.62 |
| 2021-12-31 | $2.32B | $3.62B | 0.64 |
| 2021-09-30 | $2.13B | $3.52B | 0.61 |
| 2021-06-30 | $2.01B | $3.38B | 0.59 |
| 2021-03-31 | $1.68B | $3.39B | 0.49 |
| 2020-12-31 | $1.60B | $3.23B | 0.49 |
| 2020-09-30 | $1.38B | $3.03B | 0.46 |
| 2020-06-30 | $1.18B | $2.85B | 0.42 |
| 2020-03-31 | $1.11B | $2.85B | 0.39 |
| 2019-12-31 | $1.16B | $1.35B | 0.86 |
| 2019-09-30 | $1.05B | $1.31B | 0.80 |
| 2019-06-30 | $0.97B | $1.37B | 0.71 |
| 2019-03-31 | $0.98B | $1.26B | 0.78 |
| 2018-12-31 | $0.80B | $1.25B | 0.64 |
| 2018-09-30 | $0.74B | $1.19B | 0.62 |
| 2018-06-30 | $0.70B | $1.22B | 0.57 |
| 2018-03-31 | $0.66B | $1.13B | 0.58 |
| 2017-12-31 | $0.63B | $1.15B | 0.55 |
| 2017-09-30 | $0.52B | $1.18B | 0.44 |
| 2017-06-30 | $0.47B | $1.08B | 0.44 |
| 2017-03-31 | $0.41B | $1.05B | 0.40 |
| 2016-12-31 | $0.40B | $1.00B | 0.40 |
| 2016-09-30 | $0.39B | $0.97B | 0.40 |
| 2016-06-30 | $0.34B | $0.91B | 0.38 |
| 2016-03-31 | $0.32B | $0.89B | 0.35 |
| 2015-12-31 | $0.31B | $0.85B | 0.37 |
| 2015-09-30 | $0.28B | $0.80B | 0.35 |
| 2015-06-30 | $0.26B | $0.77B | 0.34 |
| 2015-03-31 | $0.24B | $0.79B | 0.30 |
| 2014-12-31 | $0.24B | $0.75B | 0.31 |
| 2014-09-30 | $0.23B | $0.72B | 0.31 |
| 2014-06-30 | $0.21B | $0.68B | 0.31 |
| 2014-03-31 | $0.19B | $0.70B | 0.27 |
| 2013-12-31 | $0.20B | $0.63B | 0.31 |
| 2013-09-30 | $0.18B | $0.58B | 0.32 |
| 2013-06-30 | $0.18B | $0.52B | 0.35 |
| 2013-03-31 | $0.17B | $0.56B | 0.29 |
| 2012-12-31 | $0.18B | $0.58B | 0.30 |
| 2012-09-30 | $0.17B | $0.60B | 0.28 |
| 2012-06-30 | $0.16B | $0.59B | 0.27 |
| 2012-03-31 | $0.15B | $0.52B | 0.28 |
| 2011-12-31 | $0.16B | $0.49B | 0.32 |
| 2011-09-30 | $0.13B | $0.46B | 0.28 |
| 2011-06-30 | $0.12B | $0.43B | 0.27 |
| 2011-03-31 | $0.10B | $0.40B | 0.24 |
| 2010-12-31 | $0.10B | $0.38B | 0.26 |
| 2010-09-30 | $0.09B | $0.36B | 0.24 |
| 2010-06-30 | $0.08B | $0.33B | 0.22 |
| 2010-03-31 | $0.08B | $0.30B | 0.26 |
| 2009-12-31 | $0.08B | $0.27B | 0.30 |
| 2009-09-30 | $0.07B | $0.26B | 0.28 |
| 2009-06-30 | $0.07B | $0.24B | 0.29 |
| 2009-03-31 | $0.06B | $0.23B | 0.27 |
| 2008-12-31 | $0.06B | $0.22B | 0.28 |
| 2008-09-30 | $0.06B | $0.16B | 0.36 |
| 2008-06-30 | $0.06B | $0.16B | 0.36 |
| 2008-03-31 | $0.05B | $0.18B | 0.31 |
| 2007-12-31 | $0.06B | $0.16B | 0.38 |
| 2007-09-30 | $0.06B | $0.15B | 0.37 |
| 2007-06-30 | $0.05B | $0.13B | 0.42 |
| 2007-03-31 | $0.06B | $0.10B | 0.59 |
| 2006-12-31 | $0.07B | $0.08B | 0.81 |
| 2006-09-30 | $0.07B | $0.09B | 0.74 |
| 2006-06-30 | $0.05B | $0.10B | 0.47 |
| 2006-03-31 | $0.05B | $0.10B | 0.51 |
| 2005-12-31 | $0.05B | $0.09B | 0.52 |
| 2005-09-30 | $0.05B | $0.09B | 0.57 |
| 2005-06-30 | $0.05B | $0.09B | 0.58 |
| 2005-03-31 | $0.05B | $0.09B | 0.51 |
| 2004-12-31 | $0.05B | $0.09B | 0.53 |
| 2004-09-30 | $0.04B | $0.08B | 0.50 |
| 2004-06-30 | $0.04B | $0.08B | 0.51 |
| 2004-03-31 | $0.04B | $0.07B | 0.51 |
| 2003-12-31 | $0.04B | $0.06B | 0.62 |
| 2003-09-30 | $0.04B | $0.06B | 0.65 |
| 2003-06-30 | $0.04B | $0.06B | 0.65 |
| 2003-03-31 | $0.02B | $0.07B | 0.35 |
| 2002-12-31 | $0.03B | $0.06B | 0.44 |
| 2002-09-30 | $0.02B | $0.06B | 0.26 |
| 2002-06-30 | $0.02B | $0.07B | 0.25 |
| 2002-03-31 | $0.02B | $0.09B | 0.20 |
| 2001-12-31 | $0.02B | $0.10B | 0.19 |
| 2001-09-30 | $0.02B | $0.12B | 0.14 |
| 2001-06-30 | $0.02B | $0.13B | 0.13 |
| 2001-03-31 | $0.02B | $0.15B | 0.16 |
| 2000-12-31 | $0.16B | $-0.09B | -1.83 |
| 2000-09-30 | $0.00B | 0.00 | |
| 2000-06-30 | $0.00B | 0.00 | |
| 2000-03-31 | $0.00B | 0.00 | |
| 1999-12-31 | $0.00B | $0.01B | 0.28 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $12.400B | $4.035B |
| Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |